Royalty Pharma: Q2 Earnings Insights - Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma RPRX reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Royalty Pharma missed estimated earnings by 10.26%, reporting an EPS of $0.7 versus an estimate of $0.78.

Revenue was down $19.05 million from the same period last year.

Last quarter the company missed on EPS by $0.13 which was followed by a 2.58% drop in the share price the next day.

Here's a look at Royalty Pharma's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	0.73	0.77		0.69
EPS Actual	0.60	0.80	0.24	0.73
Revenue Estimate	599.76M	556.79M	578.20M	483.42M
Revenue Actual	562.00M	576.00M	585.77M	555.00M

To track all earnings releases for Royalty Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.